182 related articles for article (PubMed ID: 29650840)
1. [A Case of Effective Palliative Care with CART for Refractory Ascites Associated with Cancerous Peritonitis of Gastric Cancer].
Kawada J; Nishino M; Hata T; Ogino T; Hoshino H; Okano M; Nagai K; Kim Y; Okuyama M; Tsujinaka T
Gan To Kagaku Ryoho; 2018 Apr; 45(4):700-702. PubMed ID: 29650840
[TBL] [Abstract][Full Text] [Related]
2. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
[TBL] [Abstract][Full Text] [Related]
3. [A New Treatment Strategy-Novel Cell-Free and Concentrated Ascites Reinfusion System(KM-CART)for Massive Malignant Ascites].
Matsusaki K
Gan To Kagaku Ryoho; 2016 Dec; 43(13):2490-2497. PubMed ID: 28028255
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Cell-Free and Concentrated Ascites Reinfusion Therapy for Palliative Care in a Patient with Malignant Pleural Mesothelioma: A Case Report.
Hisakane K; Ohmatsu H; Umemura S; Kirita K; Matsumoto S; Yoh K; Niho S; Goto K
J Nippon Med Sch; 2017; 84(5):231-236. PubMed ID: 29142184
[TBL] [Abstract][Full Text] [Related]
5. [Two cases of advanced gastric cancer with peritonitis carcinomatosa that showed disappearance of ascites and obtained a good quality of life by using DIF and paclitaxel].
Okumura K; Tani S; Shiogai Y; Kodama M; Mekata E; Tan T
Gan To Kagaku Ryoho; 2012 Apr; 39(4):667-70. PubMed ID: 22504699
[TBL] [Abstract][Full Text] [Related]
6. Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites associated with cancerous peritonitis: its effect and future perspectives.
; Matsusaki K; Ohta K; Yoshizawa A; Gyoda Y
Int J Clin Oncol; 2011 Aug; 16(4):395-400. PubMed ID: 21347629
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Patients and Their Ascites Who Underwent Repeated Cell-Free and Concentrated Ascites Reinfusion Therapy.
Maeda S; Yabuuchi J; Nobuta H; Makiishi T; Hirose K
Ther Apher Dial; 2015 Aug; 19(4):342-8. PubMed ID: 26386222
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of 5-Fluorouracil and Leucovorin Combined with Weekly Paclitaxel in Advanced Gastric Cancer].
Kawada J; Nishino M; Hosoda Y; Hoshino H; Okano M; Nagai K; Okuyama M; Kim Y; Tsujinaka T
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1951-1953. PubMed ID: 28133186
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of concentrated ascites reinfusion therapy (CART) for gynecological cancer patients with refractory massive ascites due to cancerous peritonitis.
Togami S; Hori S; Kamio M; Matsuo T; Yoshinaga M; Douchi T
Eur J Gynaecol Oncol; 2014; 35(3):301-3. PubMed ID: 24984546
[TBL] [Abstract][Full Text] [Related]
10. [A case of advanced gastric cancer with carcinomatosa peritonitis effectively treated by 5-FU and low-dose CDDP therapy].
Saito E; Kunii Y; Wada G; Tsuchiya S; Yamasaki T; Sakakibara N
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1153-6. PubMed ID: 9239170
[TBL] [Abstract][Full Text] [Related]
11. [A Case of Unresectable Pancreatic Cancer with Massive Cancerous Ascites Responsive to KM-CART].
Shirakawa K; Hirahara S; Kubota H; Kuhara Y; Toyota K; Yano R; Kobayashi H; Hashimoto Y; Yokoyama Y; Sakashita Y; Miyamoto K
Gan To Kagaku Ryoho; 2021 Jan; 48(1):81-83. PubMed ID: 33468729
[TBL] [Abstract][Full Text] [Related]
12. [Two Cases of Peritoneal Dissemination of Gastric Cancer Treated with CART Followed by Chemotherapy].
Kitagawa Y; Katsuno A; Tamura N; Harada T; Abe S; Hamasaki S; Machida T; Nakanishi A; Ami K; Umetani N
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1887-1889. PubMed ID: 33468862
[TBL] [Abstract][Full Text] [Related]
13. Multicenter feasibility study of combination therapy with fluorouracil, leucovorin and paclitaxel (FLTAX) for peritoneal disseminated gastric cancer with massive ascites or inadequate oral intake.
Iwasa S; Goto M; Yasui H; Nishina T; Takahari D; Nakayama N; Taira K; Kusaba H; Fuse N; Hironaka S; Shimada Y; Nakajima TE
Jpn J Clin Oncol; 2012 Sep; 42(9):787-93. PubMed ID: 22782960
[TBL] [Abstract][Full Text] [Related]
14. [A case of unresectable gastric cancer in a patient who maintained a good quality of life with multidisciplinary treatment].
Kato R; Okada K; Ebisui C; Wada Y; Makino S; Takeoka T; Yanagisawa T; Okamura S; Fukuchi N; Murata K; Yokouchi H; Kinuta M
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2280-2. PubMed ID: 24394085
[TBL] [Abstract][Full Text] [Related]
15. [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Nakamura T; Shimada K; Okubo Y; Tanaka S; Tanabe S; Yoshida M; Doi K; Uchinami M; Horiuchi T; Tanaka K
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1423-6. PubMed ID: 15446570
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Concentrated Ascites Reinfusion Therapy(CART)for Abundant Refractory Ascites in Cecal Cancer with Peritoneal Dissemination Followed by the Readministration of Chemotherapy].
Maemura K; Urakawa S; Kato J; Kidogami S; Fukata T; Nishida H; Ohigashi H; Takemoto H; Fukuzaki T
Gan To Kagaku Ryoho; 2024 Jan; 51(1):93-95. PubMed ID: 38247103
[TBL] [Abstract][Full Text] [Related]
17. Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report.
Yasuda K; Asou M; Asakawa T; Araki M
J Med Case Rep; 2020 Oct; 14(1):192. PubMed ID: 33050943
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites.
Kawata Y; Nagasaka K; Matsumoto Y; Oda K; Tanikawa M; Sone K; Mori-Uchino M; Tsuruga T; Arimoto T; Osuga Y; Fujii T
Int J Clin Oncol; 2019 Apr; 24(4):420-427. PubMed ID: 30474762
[TBL] [Abstract][Full Text] [Related]
19. A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites.
Oh SY; Kwon HC; Lee S; Lee DM; Yoo HS; Kim SH; Jang JS; Kim MC; Jeong JS; Kim HJ
Jpn J Clin Oncol; 2007 Dec; 37(12):930-5. PubMed ID: 18211984
[TBL] [Abstract][Full Text] [Related]
20. [A Case of Effective Peritoneo-Venous Shunt for Refractory Malignant Ascites in a Gastric Cancer Patient with Peritoneal Dissemination].
Sugamoto Y; Arasawa T; Fukunaga T; Tasaki K; Kuboshima M; Muto Y; Sazuka T; Kimura M; Asai Y; Fujita E; Ota T; Matsubara H
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2059-2061. PubMed ID: 33468800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
